Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - NET INCOME
Net Income DMAC - DiaMedica Therapeutics Inc.
-19.4 M
LAST VALUE
-19.41%
2 YEAR CAGR
-27.58%
5 YEAR CAGR
-10.09%
10 YEAR CAGR